FDA Inspection 1198048 — Corden Pharma GmbH

Corden Pharma GmbH — FEI 3007014398

The FDA completed an inspection of Corden Pharma GmbH on September 14, 2022 in Plankstadt. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 14, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Plankstadt (Germany)

Additional Details

Mutual Recognition Agreement (MRA)